SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002011
Filing Date
2015-10-29
Accepted
2015-10-29 08:05:08
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20150930x10q.htm 10-Q 1914147
2 EX-31.1 alks-20150930ex311f79268.htm EX-31.1 42649
3 EX-31.2 alks-20150930ex312c37cde.htm EX-31.2 43080
4 EX-32.1 alks-20150930ex321ef0d60.htm EX-32.1 20457
  Complete submission text file 0001558370-15-002011.txt   7151290

Data Files

Seq Description Document Type Size
5 EX-101.INS alks-20150930.xml EX-101.INS 1640541
6 EX-101.SCH alks-20150930.xsd EX-101.SCH 40177
7 EX-101.CAL alks-20150930_cal.xml EX-101.CAL 68958
8 EX-101.DEF alks-20150930_def.xml EX-101.DEF 118222
9 EX-101.LAB alks-20150930_lab.xml EX-101.LAB 423162
10 EX-101.PRE alks-20150930_pre.xml EX-101.PRE 284996
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 151181827
SIC: 2834 Pharmaceutical Preparations